@Paperchasin @Darkwatcher ......hrtx..... - opioid crisis play - check FDA addressing the issue, Biden administration addressing the issue, local/state governments addressing the issue (very expensive to treat addicted folks), insurance companies addressing the issue, department of justice addressing the issue (prosecuting), larger pharma’s addressing the issue - downside risk to $18.50-ish MAX IMHO - if the drug is approved, this will be in play for the next 1-2 years or more IMHO When, industry, payers and the policy makes are behind your product, it’s hard to lose.... $37, $40, ($60-$100....over time).... IMHO